Medplus Health Services Limited (MEDPLUS) - Total Liabilities
Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has total liabilities worth Rs19.58 Billion INR (≈ $211.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Medplus Health Services Limited to track the company's year-over-year net asset growth rate.
Medplus Health Services Limited - Total Liabilities Trend (2019–2026)
This chart illustrates how Medplus Health Services Limited's total liabilities have evolved over time, based on quarterly financial data. See Medplus Health Services Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Medplus Health Services Limited Competitors by Total Liabilities
The table below lists competitors of Medplus Health Services Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Emperor of Cleaning Hi-Tech Co Ltd
SHG:603200
|
China | CN¥548.17 Million |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥13.05 Billion |
|
Harbin Xinguang Optic Electronics
SHG:688011
|
China | CN¥174.65 Million |
|
EQ Resources Ltd
AU:EQR
|
Australia | AU$115.21 Million |
|
Ningxia Building Materials Group Co Ltd
SHG:600449
|
China | CN¥1.60 Billion |
|
Jiangxi Guoguang Commercial Chains Co Ltd
SHG:605188
|
China | CN¥1.61 Billion |
|
Fujian Qingshan Paper Industry Co Ltd
SHG:600103
|
China | CN¥1.66 Billion |
|
Greenworks (Jiangsu) Co. Ltd. A
SHE:301260
|
China | CN¥6.40 Billion |
Liability Composition Analysis (2019–2026)
This chart breaks down Medplus Health Services Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MEDPLUS stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medplus Health Services Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medplus Health Services Limited (2019–2026)
The table below shows the annual total liabilities of Medplus Health Services Limited from 2019 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs19.58 Billion ≈ $211.74 Million |
+20.84% |
| 2025-03-31 | Rs16.20 Billion ≈ $175.22 Million |
+13.50% |
| 2024-03-31 | Rs14.27 Billion ≈ $154.37 Million |
+9.28% |
| 2023-03-31 | Rs13.06 Billion ≈ $141.26 Million |
+11.00% |
| 2022-03-31 | Rs11.77 Billion ≈ $127.27 Million |
+41.01% |
| 2021-03-31 | Rs8.35 Billion ≈ $90.25 Million |
+1.83% |
| 2020-03-31 | Rs8.20 Billion ≈ $88.64 Million |
+22.81% |
| 2019-03-31 | Rs6.67 Billion ≈ $72.17 Million |
-- |
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more